The HSA‐TPP NC‐assisted MAP regimen consisting of a combination of DOX/HSA‐TPP with free CDDP and MTX/HSA‐TPP treatments displayed an enhanced synergistic effect in suppressing osteosarcoma cells, whereas conventional solution MAP showed antagonism in CI values. This evidence concerns the gene ALB and osteosarcoma.